145 related articles for article (PubMed ID: 29168085)
1. Prevalence of Human Papillomavirus Genotypes and Abnormal Pap Smears Among Women in the Military Health System.
Daly CM; Hansen SL; Kwon PO; Roberts TA
J Community Health; 2018 Jun; 43(3):441-447. PubMed ID: 29168085
[TBL] [Abstract][Full Text] [Related]
2. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
3. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program.
Luquain A; Belglaiaa E; Guenat D; Vrecko S; Riethmuller D; Valmary-Degano S; Bedgedjian I; Chouham S; Prétet JL; Mougin C
Prev Med; 2015 Dec; 81():157-62. PubMed ID: 26348451
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of high-risk human papillomavirus infection and cervical cytology abnormalities among women up to age 40 in the Tuzla Canton, Bosnia and Herzegovina.
Sadiković A; Iljazović E; Konrad Čustović M; Karasalihović Z; Avdić S
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Dec; 29(4):175-179. PubMed ID: 33348936
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women.
Winer RL; Hughes JP; Feng Q; Xi LF; Lee SK; O'Reilly SF; Kiviat NB; Koutsky LA
Sex Transm Dis; 2012 Nov; 39(11):848-56. PubMed ID: 23064533
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium.
Vorsters A; Cornelissen T; Leuridan E; Bogers J; Vanden Broeck D; Benoy I; Goossens H; Hens N; Van Damme P
BMC Public Health; 2016 Jun; 16():477. PubMed ID: 27266509
[TBL] [Abstract][Full Text] [Related]
9. Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection.
Kero K; Rautava J; Syrjänen K; Grenman S; Syrjänen S
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2215-2219. PubMed ID: 28681204
[TBL] [Abstract][Full Text] [Related]
10. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.
Moreira ED; Oliveira BG; Ferraz FM; Costa S; Costa Filho JO; Karic G
Int J Gynecol Cancer; 2006; 16(2):599-603. PubMed ID: 16681732
[TBL] [Abstract][Full Text] [Related]
11. Retrospective Investigation of Human Papillomavirus Cervical Infection and Lymphoma Incidence: A Clinical and Pathological Evaluation.
Gardella B; Dominoni M; Pasquali MF; Gotti M; Fraticelli S; Lucioni M; Cesari S; Fiandrino G; De Silvestri A; Zerbi C; Lazic T; Arcaini L; Paulli M; Spinillo A
Gynecol Obstet Invest; 2024; 89(2):95-102. PubMed ID: 38262378
[TBL] [Abstract][Full Text] [Related]
12. Hypothesis: the act of taking a Papanicolaou smear reduces the prevalence of human papillomavirus infection: a potential impact on the risk of cervical cancer.
Shapiro S; Carrara H; Allan BR; Hoffman M; Rosenberg L; Kelly JP; Cooper DD; Williamson AL
Cancer Causes Control; 2003 Dec; 14(10):953-7. PubMed ID: 14750534
[TBL] [Abstract][Full Text] [Related]
13. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
14. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
[TBL] [Abstract][Full Text] [Related]
15. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women.
Marrazzo JM; Koutsky LA; Kiviat NB; Kuypers JM; Stine K
Am J Public Health; 2001 Jun; 91(6):947-52. PubMed ID: 11392939
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection and the association with abnormal Pap findings in Yukon, Canada.
Jiang Y; Hanley B; Brassard P; Severini A; Lo J; O'Donovan S; Duncan L; Luo ZC; Tohme S; Mao Y; Morrison H
J Low Genit Tract Dis; 2013 Jul; 17(3):346-53. PubMed ID: 23733163
[TBL] [Abstract][Full Text] [Related]
17. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Human Papillomavirus (HPV) and Other Sexually Transmitted Infections (STIs) among Italian Women Referred for a Colposcopy.
Martinelli M; Musumeci R; Sechi I; Sotgiu G; Piana A; Perdoni F; Sina F; Fruscio R; Landoni F; Cocuzza CE
Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31818033
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human papillomavirus among Croatian women attending regular gynecological visit.
Grahovac M; Racić I; Hadzisejdić I; Dorić A; Grahovac B
Coll Antropol; 2007 Apr; 31 Suppl 2():73-7. PubMed ID: 17598508
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study.
Agorastos T; Chatzistamatiou K; Zafrakas M; Siamanta V; Katsamagkas T; Constantinidis TC; Lampropoulos AF;
Eur J Cancer Prev; 2014 Sep; 23(5):425-31. PubMed ID: 24977385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
